Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:498-503
Published online before print January 22, 2004, doi: 10.1161/01.ATV.0000118012.64932.f4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
24/3/498    most recent
01.ATV.0000118012.64932.f4v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silaste, M.-L.
Right arrow Articles by Hörkkö, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silaste, M.-L.
Right arrow Articles by Hörkkö, S.
Related Collections
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:498.)
© 2004 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Changes in Dietary Fat Intake Alter Plasma Levels of Oxidized Low-Density Lipoprotein and Lipoprotein(a)

Marja-Leena Silaste; Maire Rantala; Georg Alfthan; Antti Aro; Joseph L. Witztum; Y. Antero Kesäniemi; Sohvi Hörkkö

From the Department of Internal Medicine and Biocenter Oulu (M.-L.S., M.R., Y.A.K., S.H.), University of Oulu, Oulu, Finland; the National Public Health Institute (G.A., A.A.), Mannerheimintie, Helsinki, Finland; and the Department of Medicine (J.L.W.), University of California San Diego, La Jolla, Calif.

Correspondence to Marja-Leena Silaste, Department of Internal Medicine, University of Oulu, P.O. Box 5000, FIN-90014 Oulu, Finland. E-mail Marja-Leena.Silaste{at}oulu.fi

Objective— To assess the effects of dietary modifications on oxidized low-density lipoprotein (LDL).

Methods and Results— Thirty-seven healthy women were fed two diets. Both diets contained a reduced amount of total and saturated fat. In addition, one diet was low in vegetables and the other was high in vegetables, berries, and fruit. The dietary intake of total fat was 70 g per day at baseline and decreased to 56 g (low-fat, low-vegetable diet) and to 59 g (low-fat, high-vegetable diet). The saturated fat intake decreased from 28 g to 20 g and to 19 g, and the amount of polyunsaturated fat intake increased from 11 g to 13 g and to 19 g (baseline; low-fat, low-vegetable; low-fat, high-vegetable; respectively). The amount of oxidized LDL in plasma was determined as the content of oxidized phospholipid per ApoB-100 using a monoclonal antibody EO6 (OxLDL-EO6). The median plasma OxLDL-EO6 increased by 27% (P<0.01) in response to the low-fat, low-vegetable diet and 19% (P<0.01) in response to the low-fat, high-vegetable diet. Also, the Lp(a) concentration was increased by 7% (P<0.01) and 9% (P=0.01), respectively.

Conclusion— Alterations in the dietary fat intake resulted in increased plasma concentrations of lipoprotein(a) and OxLDL-EO6.


Key Words: antioxidants • intervention • lipoprotein (a) • oxidized low-density lipoprotein • polyunsaturated fat




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
A. E. Fraley, G. G. Schwartz, A. G. Olsson, S. Kinlay, M. Szarek, N. Rifai, P. Libby, P. Ganz, J. L. Witztum, S. Tsimikas, et al.
Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
J. Am. Coll. Cardiol., June 9, 2009; 53(23): 2186 - 2196.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Kato, C. Mori, K. Kitazato, S. Arata, T. Obama, M. Mori, K. Takahashi, T. Aiuchi, T. Takano, and H. Itabe
Transient Increase in Plasma Oxidized LDL During the Progression of Atherosclerosis in Apolipoprotein E Knockout Mice
Arterioscler Thromb Vasc Biol, January 1, 2009; 29(1): 33 - 39.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. Bergmark, A. Dewan, A. Orsoni, E. Merki, E. R. Miller, M.-J. Shin, C. J. Binder, S. Horkko, R. M. Krauss, M. J. Chapman, et al.
A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma
J. Lipid Res., October 1, 2008; 49(10): 2230 - 2239.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Merki, M. J. Graham, A. E. Mullick, E. R. Miller, R. M. Crooke, R. E. Pitas, J. L. Witztum, and S. Tsimikas
Antisense Oligonucleotide Directed to Human Apolipoprotein B-100 Reduces Lipoprotein(a) Levels and Oxidized Phospholipids on Human Apolipoprotein B-100 Particles in Lipoprotein(a) Transgenic Mice
Circulation, August 12, 2008; 118(7): 743 - 753.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Choi, A. Chae, E. Miller, M. Messig, F. Ntanios, A. N. DeMaria, S. E. Nissen, J. L. Witztum, and S. Tsimikas
Relationship Between Biomarkers of Oxidized Low-Density Lipoprotein, Statin Therapy, Quantitative Coronary Angiography, and Atheroma Volume Observations From the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) Study.
J. Am. Coll. Cardiol., July 1, 2008; 52(1): 24 - 32.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Ky, A. Burke, S. Tsimikas, M. L. Wolfe, M. G. Tadesse, P. O. Szapary, J. L. Witztum, G. A. FitzGerald, and D. J. Rader
The Influence of Pravastatin and Atorvastatin on Markers of Oxidative Stress in Hypercholesterolemic Humans
J. Am. Coll. Cardiol., April 29, 2008; 51(17): 1653 - 1662.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. Berglund, M. Lefevre, H. N Ginsberg, P. M Kris-Etherton, P. J Elmer, P. W Stewart, A. Ershow, T. A Pearson, B. H Dennis, P. S Roheim, et al.
Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states
Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1611 - 1620.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. K. Schindhelm, M. Alssema, P. G. Scheffer, M. Diamant, J. M. Dekker, R. Barto, G. Nijpels, P. J. Kostense, R. J. Heine, C. G. Schalkwijk, et al.
Fasting and Postprandial Glycoxidative and Lipoxidative Stress Are Increased in Women With Type 2 Diabetes
Diabetes Care, July 1, 2007; 30(7): 1789 - 1794.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M.-P. St-Onge, I. Aban, A. Bosarge, B. Gower, K. D Hecker, and D. B Allison
Snack chips fried in corn oil alleviate cardiovascular disease risk factors when substituted for low-fat or high-fat snacks
Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1503 - 1510.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M.-J. Shin, P. J Blanche, R. S Rawlings, H. S Fernstrom, and R. M Krauss
Increased plasma concentrations of lipoprotein(a) during a low-fat, high-carbohydrate diet are associated with increased plasma concentrations of apolipoprotein C-III bound to apolipoprotein B-containing lipoproteins
Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1527 - 1532.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Tsimikas, M. Aikawa, F. J. Miller Jr, E. R. Miller, M. Torzewski, S. R. Lentz, C. Bergmark, D. D. Heistad, P. Libby, and J. L. Witztum
Increased Plasma Oxidized Phospholipid:Apolipoprotein B-100 Ratio With Concomitant Depletion of Oxidized Phospholipids From Atherosclerotic Lesions After Dietary Lipid-Lowering: A Potential Biomarker of Early Atherosclerosis Regression
Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 175 - 181.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Tuominen, Y. I. Miller, L. F. Hansen, Y. A. Kesaniemi, J. L. Witztum, and S. Horkko
A Natural Antibody to Oxidized Cardiolipin Binds to Oxidized Low-Density Lipoprotein, Apoptotic Cells, and Atherosclerotic Lesions
Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 2096 - 2102.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. E. Griel, E. H. Ruder, and P. M. Kris-Etherton
The Changing Roles of Dietary Carbohydrates: From Simple to Complex
Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 1958 - 1965.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Tsimikas, S. Kiechl, J. Willeit, M. Mayr, E. R. Miller, F. Kronenberg, Q. Xu, C. Bergmark, S. Weger, F. Oberhollenzer, et al.
Oxidized Phospholipids Predict the Presence and Progression of Carotid and Femoral Atherosclerosis and Symptomatic Cardiovascular Disease: Five-Year Prospective Results From the Bruneck Study
J. Am. Coll. Cardiol., June 6, 2006; 47(11): 2219 - 2228.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Rodenburg, M. N. Vissers, A. Wiegman, E. R. Miller, P. M. Ridker, J. L. Witztum, J. J.P. Kastelein, and S. Tsimikas
Oxidized Low-Density Lipoprotein in Children With Familial Hypercholesterolemia and Unaffected Siblings: Effect of Pravastatin
J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1803 - 1810.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. J. van Tits, J. de Graaf, A. F. Stalenhoef, S. Tsimikas, J. L. Witztum, E. R. Miller, W. J. Sasiela, M. Szarek, A. G. Olsson, and G. G. Schwartz
Letter Regarding Article by Tsimikas et al, "High-Dose Atorvastatin Reduces Total Plasma Levels of Oxidized Phospholipids and Immune Complexes Present on Apolipoprotein B-100 in Patients With Acute Coronary Syndromes in the MIRACL Trial" * Response
Circulation, May 10, 2005; 111(18): e284 - e285.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Berglund and R. Ramakrishnan
Lipoprotein(a): An Elusive Cardiovascular Risk Factor
Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2219 - 2226.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Tsimikas, J. L. Witztum, E. R. Miller, W. J. Sasiela, M. Szarek, A. G. Olsson, G. G. Schwartz, and for the Myocardial Ischemia Reduction with Aggress
High-Dose Atorvastatin Reduces Total Plasma Levels of Oxidized Phospholipids and Immune Complexes Present on Apolipoprotein B-100 in Patients With Acute Coronary Syndromes in the MIRACL Trial
Circulation, September 14, 2004; 110(11): 1406 - 1412.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Navab, S. T. Reddy, B. J. Van Lenten, and A. M. Fogelman
Apparent Paradox of Low-Fat "Healthy" Diets Increasing Plasma Levels of Oxidized Low-Density Lipoprotein and Lipoprotein(a)
Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 392 - 393.
[Full Text]